Creative Bioarray is excited to announce the launch of its comprehensive Drug Metabolism and Pharmacokinetics (DMPK) Services which designed to streamline drug development by providing critical ...

It may sound harsh, but drug candidates that are bound to be poor performers should be identified sooner rather than later—and ruthlessly eliminated from development. Granted, early in development, ...

ADMETox profiling has assumed centerstage in the drug discovery process since the late 1990s. ADMETox studies map the absorption, distribution, metabolism, excretion, and toxicity readouts of drugs or ...

CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced the expansion of its Contract Research Services (CRS ...

The in vitro assays from CN-Bio are effective in predicting clinical outcomes. High-functioning, metabolically competent human single- and multi-organ models are used in studies on drug metabolism, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Woburn biotech company BioTrove Inc. and New Jersey drug ...

Research and Markets has announced the addition of the "ADME-Toxicology Testing - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for ...

DUBLIN--(BUSINESS WIRE)--The "ADME Toxicology Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's ...